Clinical, scientific and ethical aspects of fetal and neonatal care at extremely preterm periods of gestation

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 104, Issue 12, 1997, Pages 1341-1350

  Morrison, John J ^a   Rennie, Janet M ^b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ERYTHROMYCIN; METRONIDAZOLE; OXYTOCIN; RITODRINE; UTERUS SPASMOLYTIC AGENT;

BIRTH WEIGHT; ETHICS; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; MEDICAL ETHICS; NEWBORN; NEWBORN CARE; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW;

ANTI-BACTERIAL AGENTS; COUNSELING; DELIVERY, OBSTETRIC; DEVELOPMENTAL DISABILITIES; ETHICS, MEDICAL; FEMALE; FETAL DISEASES; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, PREMATURE; MATERNAL MORTALITY; OBSTETRIC LABOR, PREMATURE; PERINATAL CARE; PHYSICIAN-PATIENT RELATIONS; PREGNANCY;

EID: 0030667171     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1997.tb11002.x     Document Type: Review

References (91)

1. Morrison JJ. Prediction and prevention of preterm labour. In: Studd JWW, editor. Progress in Obstetrics and Gynaecology, Vol 12. Edinburgh: Churchill Livingstone, 1996: 67–85.
2. Allen MC, Donohue PK, Dusman AE. The limit of viability: neonatal outcome of infants born at 22 to 25 weeks gestation. N Engl J Med 1993; 329: 1597–1601.
3. Katz VL, Bose CL. Improving survival of the very premature infant. J Perinatal 1993; 13: 261–265.
4. Holtrop PC, Ertzbischoff LM, Roberts CL, Batton DG, Lorenz RP. Survival and short term outcome in newborns of 23 to 25 weeks getstaion. Am J Obstet Gynecol 1994; 170: 1266–1270.
5. Ferrara TB, Hoekstra RE, Couser RJ et al. Survival and follow up of infants born at 23 to 26 weeks of gestational age: effects of surfactant therapy. J Pediatr 1994; 124: 119–124.
6. Hagan R, Benninger H, Chiffings D, Evans S, French N. Very preterm birth: a regional study. Part 2: The very preterm infant. Br J Obstet Gynaecol 1996; 103: 239–245.
7. Bohin S, Draper ES, Field DJ. The impact of extremely immature infants on neonatal services. Arch Dis Child 1996; 74: F110–F113.
8. Rennie JM. Perinatal management at the lower margin of viability. Arch Dis Child 1996; 74: F214–F218.
9. Copper RL, Goldenberg RL, Creasy RK et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993; 168: 78–84.
10. Fanaroff AA, Wright LL, Stevenson DK et al. Very-low-birth-weight outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, May 1991 through December 1992. Am J Obstet Gynecol 1995; 173: 1423–1431.
11. Rennie JM, Wheater M, Cole TJ. Antenatal steroid administration is associated with an improved chance of intact survival in preterm infants. Eur J Pediatr 1996; 155: 576–579.
12. Worthington D, Davis LE, Grausz JP, Sobocinski K. Factors influencing survival and morbidity with Very low birth weight delivery. Obstet Gynecol 1983; 62: 550–555.
13. Vasa R, Vidyasgar D, Winegar A, Peterson P, Spellacy WN. Perinatal factors influencing the outcome of 501 to 1000 gm newborns. Clin Perinatal 1986; 13: 267–284.
14. Wolf EJ, Vintzileos AM, Rosenkrantz TS, Rodis JF, Salafia CM, Pezzullo JG. Do survival and morbidity of very-low-birth-weight infants vary according to the primary pregnancy complication that results in pretenn delivery Am J Obstet Gynecol 1993; 169: 1233–1239.
15. Iannucci TA, Tomich PG, Gianopoulos JG. Etiology and outcome of extremely low-birth-weight infants. Am J Obstet Gynecol 1996; 174: 1896–1902.
16. Wolf EJ, Vintzileos AM, Rosenkrantz TS, Rodis JF, Lettieri L, Mallozzi A. A comparison of pre-discharge survival and morbidity in singleton and twin very low birth weight infants. Obstet Gynecol 1992; 80: 436–439.
17. Yu VY, Gomez JM, Shah V, McCloud PI. Survival prospects of extremely preterm infants: a 10–year experience in a single perinatal center. Am J Perinatal 1992; 9: 164–169.
18. Cooke RWI. Factors affecting survival and outcome at 3 years in extremely preterm infants. Arch Dis Child 1994; 71: F28–F31.
19. Weissman A, Jakobi P, Blazer S, Avrahami R, Zimmer EZ. Survival and long term outcome of infants delivered at 24 to 28 weeks gestation by method of delivery and fetal presentation. J Perinatal 1989; 9: 372–375.
20. Wariyar U, Richmond S, Hey E. Pregnancy outcome at 24–31 weeks gestation: neonatal survivors. Arch Dis Child 1989; 64: 670–677.
21. Synnes AR, Ling EWY, Whitfield MF et al. Perinatal outcomes of a large cohort of extremely low gestational age infants (twenty-three to twenty-eight completed weeks of gestation). J Pediatr 1994; 125: 952–960.
22. Johnson A, Townshend P, Yudkin P, Bull D, Wilkinson AR. Functional abilities at age 4 years of children born before 29 weeks gestation. BMJ 1993; 306: 1715–1717.
23. Eg-Andersen G. Prediction of outcome in 164 infants bom after 24 to 28 weeks gestation. Acta Paediatrica Scand 1989; 360: 56–61.
24. Ruys JH, Veerlove-Vanborick SP, Den Ouden AL. The viability of the pretenn infant. Eur J Obstet Gynaecol Reprod Biol 1989; 33: 31–37.
25. Kuban KCK, Leviton A. Cerebral palsy. N Engl J Med 1994; 330: 188–195.
26. Stanley FJ. Survival and cerebral palsy in low birthweight infants: implications for perinatal care. Paediatr Perinat Epidemiol 1992; 6: 298–310.
27. Pharoah POD, Cooke T, Cooke RWI, Rosenbloom L. Birth-weight specific trends in cerebral palsy. Arch Dis Child 1990; 65: 602–606.
28. Escobar GJ, Littenberg B, Petitti DB. Outcome among surviving very low birthweight infants: a meta-analysis. Arch Dis Child 1991; 66: 204–211.
29. Stanley FJ, Watson L. Trends in perinatal mortality and cerebral palsy in Western Australia, 1967-1985. BMJ 1992; 304: 658–663.
30. Other direct deaths. In Hibbard BM et al editors. Report on Confidential Enquiry into Maternak Deaths in the United Kingdom. London: HMSO 1996; 104–109.
31. Halperin ME, Moore DC, Hannah WJ. Classical versus low-segment transverse incision for preterm caesarean section: maternal complications and outcome of subsequent pregnancies. Br J Obstet Gynaecol 1988; 95: 990–996.
32. Lao TT, Halpem SH, Crosby ET, Huh C. Uterine incision and maternal blood loss in preterm caesarean section. Arch Gynecol Obstet 1993; 252: 113–117.
33. Canadian Preterm Labor Investigators Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308–312.
34. Rib DM, Sherer DM, Woods JR Jr. Maternal and neonatal outcome associated with prolonged premature rupture of membranes below 26 weeks’ gestation. Am J Perinatal 1993; 10: 369–373.
35. Crowley P. Corticosteroids prior to preterm delivery. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews [updated 6 Sep 1996]. Available in The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration; Issue 3. Oxford: Update Software; 1996. [Updated quarterly. Available from: London: BMJ Publishing Group.].
36. Schellenberg JC, Liggins GC, Manzai M, Kitterman JA, Le CCH. Synergistic hormonal effects on lung maturation in fetal sheep. J Appl Physiol 1988; 65: 94–100.
37. Crowther C, Alfirevic Z. Antenatal thyrotropin-releasing hormone (TRH) prior to preterm delivery. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews [updated 6 Sep 1996]. Available in The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration; Issue 3. Oxford: Update Software; 1996. [Updated quarterly. Available from: BMJ Publishing Group, London.].
38. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for pretenn labor. N Engl J Med 1993; 329: 1602–1607.
39. Leonardi MR, Hankins GDV. What’s new in tocolytics Clin Perinatal 1992; 19: 367–384.
40. Petrie RH. Tocolysis using magnesium sulfate. Semin Perinatal 1981; 5: 256–273.
41. Morrison JJ, Ashford MLJ, Khan RN, Smith SK. The effects of potassium channel openers on the isolated human pregnant myomctrium before and after the onset of labour: potential for tocolysis. Am J Obstet Gynecol 1993; 169: 1277–1285.
42. Morrison JJ, Perera D, O’Brien P, Marshall I, Rodeck CH. Effects of nitric oxide (NO) substrate, NO donors and NO synthase inhibitors on contractions of isolated human myometrium. Br J Obstet Gynaecol 1996; 103: 483–484.
43. Goodwin TM, Paul R, Silver H et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Ohstet Gynecol 1994; 170: 474–479.
44. King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: an overview of the randomised controlled trials. Br J Ohstet Gynaecol 1988; 95: 211–222.
45. Hadi HA, Albazzaz SJ. Measurement of pulmonary capillary pressure during ritodrine tocolysis in twin pregnancies: a new noninvasive technique. Am J Perinatal 1993; 10: 351–353.
46. Gabriel R, Harika G, Saniez D, Durot S, Quereux C, Wahl P. Prolonged intravenous ritodrine therapy: a comparison between multiple and singleton pregnancies. Eur J Obstet Gynecol Reprod Biol 1994; 57: 65–71.
47. McGregor JA, French Jl, Seo K. Adjunctive clindamycin therapy for preterm labor: results of a double-blind, placebo-controlled trial. Am J Obstet Gynecol 1991; 165: 867–875.
48. Newton ER, Dinsmoor MJ, Gibbs RS. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol 1989; 74: 562–566.
49. Morales WJ, Angel JL, O’Brien WF, Knuppel RA, Finazzo F. A randomized study of antibiotic therapy in idiopathic pretenn labor. Obstet Gynecol 1988; 72: 829–833.
50. Romero R, Sibai B, Caritis S et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 169: 764–774.
51. Crowley P. Antibiotics in preterm labour with intact membranes. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews, 1995 [updated 24 Feb 1995]. Available from: London: BMJ Publishing Group.
52. Gordon M, Samuels P, Shubert P, Johnson F, Gebauer C, Iams J. A randomized, prospective study of adjunctive ceftizpximc in preterm labor. Am J Obstet Gynecol 1995; 172: 1546–1552.
53. Hauth JC, Goldenberg RL, Andrews WW, DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–1736.
54. McDonald HM, O’Loughlin JA, Vigneswaran R et al. Impact of metronidazole therapy on pretenn birth In women with bacterial vaginosis flora (Gardnerella vaginalis): a randomised placebo controlled trial. Br J Obstet Gynaecol 1997; 104: 1391–1397.
55. Crowley P. Antibiotics for preterm prelabour rupture of membranes. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews, 1995 [updated 24th February 1995], Available from: London: BMJ Publishing Group.
56. MacDougall J, Siddle N. Emergency cervical cerclage. Br J Obstet Gynaecol 1991; 98: 1234–1238.
57. Wong GP, Farquharson DF, Dansereau J. Emergency cervical cerclage: a retrospective review of 51 cases. Am J Perinatal 1993; 10: 341–347.
58. Aarts JM, Brons JT, Bruinse HW. Emergency cervical cerclage. Obstet Gynecol Surv 1995; 50: 459–469.
59. Olatunbosun OA, al Nuaim L, Turnell RW. Emergency cerclage compared with bed rest for advanced cervical dilatation in pregnancy. Int Surg 1995; 80: 170–174.
60. Grant A. Elective versus selective caesarean delivery of the small baby. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, editors. Pregnancy and Childbirth Module of The Cochrane Database of Systematic Reviews [updated 6 Sep 1996]. Available in The Cochrane Library [database on disk and CDROM]. The Cochrane Collaboration; Issue 3. Oxford: Update Software, 1996. [Updated quarterly. Available from: London: BMJ Publishing Group.].
61. Sims DG, Heal CA, Battle SM. Use of adrenaline and atropine in neonatal resuscitation. Arch Dis Child 1994; 70: F3–F9.
62. Sood S, Giacoia P. Cardiopulmonary resuscitation in very low birth-weight infants. Am J Perinatal 1992; 9: 130–133.
63. Schellenberg J-C, Liggins GC. Initiation of labour: uterine and cervical changes, endocrine changes. In: Chard T, Grudzinskas JG, editors. The Uterus. Cambridge: Cambridge University Press 1994; 308–336.
64. Morrison JJ. Physiology and pharmacology of uterine contractility during pregnancy and labour. In: Studd JWW, editor. RCOG Yearbook. London: RCOG Press 1996; 45–61.
65. Young RC, Herndon Smith L, Anderson NC. Passive membrane properties and inward calcium current of human uterine smooth muscle cells. Am J Obstet Gynecol 1991; 164: 1132–1139.
66. Yallampali C, Garfield RE, Byam-Smith M. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology 1993; 133: 1899–1902.
67. Bacon CR, Morrison JJ, O’Reilly G, Cameron IT, Davenport AP. ETα and ETβ endothelin receptors in human myometrium characterized by the subtype elective ligands BQ123, BQ3020, FR139317 and PD151242. J Endocrinol 1995; 144: 127–134.
68. O’Reilly G, Charnock-Jones DS, Morrison JJ, Cameron IT, Davenport AP, Smith SK. Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Comm 1993; 193: 834–840.
69. +-channel properties of human myometrium during pregnancy and labour. Proc R Soc Lond [Biol] 1993; 251: 9–15.
70. Morrison JJ, Charnock-Jones DS, Smith SK. Messenger RNA encoding thiol protein disulphide isomerase in amnion, chorion and placenta in human term and preterm labour. Br J Obstet Gynaecol 1996; 103: 873–879.
71. Challis JR. CRH, a placental clock and preterm labour. Nat Med 1995; 1: 416.
72. Morrison JJ, Smith SK. Prostaglandins and uterine activity. In: Chard T, Grudzinskas JG, editors. The Uterus. Cambridge: Cambridge University Press 1994; 230–251.
73. Diamond J. β-Adrenereceptors, cyclic AMP, and cyclic GMP in control of uterine motility. In: Carsten ME, Miller JD editors. Uterine Function: Molecular and Cellular Aspects. New York: Plenum Press 1990: 249–275.
74. Cole WC, Garfield RE, Kirkaldy JS. Gap junctions and direct intercellular communication between rat uterine smooth muscle cells. Am J Physiol 1988; 249: C20–C31.
75. Mercer BM, Goldenberg RL, Das A. The preterm prediction study: a clinical assessment system. Am J Obstet Gynecol 1996; 174: 1885–1895.
76. Papiernik E, Bouyer J, Collin D et al. Precocious cervical ripening and preterm labor. Obstet Gynecol 1986; 67: 238–242.
77. Andersen HF, Nugent CE, Wanty SD, Hayashi RH. Prediction of risk for preterm delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1990; 163: 859–867.
78. Hellemans P, Gerris J, Verdonk P. Fetal fibronectin detection of preterm birth in low risk women. Br J Obstet Gynaecol 1995; 102: 207–212.
79. Jackson GM, McGregor JA, Lachelin GCL, Goodwin TM, Artal R, Dullien V. Salivary estriol rise predicts preterm labor. Am J Obstet Gynecol 1995; 172: 406.
80. Petersen LK, Skajaa K, Uldberg N. Serum relaxin as a potential marker for preterm labour. Br J Obstet Gynaecol 1992; 99: 292–295.
81. Morrison JJ, Clark IM, Powell EK, Cawston TE, Hackett GA, Smith SK. Tissue collagenase: serum levels during pregnancy and parturition. Eur J Obstet Gynaecol Reprod Biol 1994; 54: 71–75.
82. Clark IM, Morrison JJ, Hackett GA, Powell EK, Cawston TE, Smith SK. Tissue inhibitor of metalloproleinases: serum levels during pregnancy and labor, term and preterm. Obstet Gynecol 1994; 83: 532–537.
83. Warren WB, Patrick SL, Goland RS. Elevated maternal plasma corti-cotrophin releasing hormone levels in pregnancies complicated by preterm labor. Am J Obstet Gynecol 1992; 166: 1198–1204.
84. Lockwood CJ. The diagnosis of preterm labour and the prediction of preterm delivery. Clin Obstet Gynecol 1995; 38: 675–687.
85. Morrison JJ, Beam SR, Smith SK, Ahmed A. Activation of protein kinase C is required for oxytocin-induced contractility in human pregnant myometrium. Hum Reprod 1996; 10: 2285–2290.
86. Weston AH, Edwards G. Recent progress in potassium channel opener pharmacology. Biochem Pharmacol 1992; 43: 47–54.
87. Paris JJ. Manslaughter or a legitimate parental decision? The Messenger case. J Perinatal 1996; 16: 61–66.
88. Hahn RA. Perinatal ethics in anthropological perspective. In: Weil WB Jr, Benjamin M, editors. Ethical Issues at the Onset of Life. Boston: Blackwell Science, 1987: 213–218.
89. Yellin PB, Fleischman AR. DNR in the DR. J Perinatal 1995; 15: 232–236.
90. Alecson DG. DNR in the DR [letter]. J Perinatal 1995; 15: 520–522.
91. Morrison JJ, Rennie JM. Changing the definition of perinatal mortality. Lancet 1995; 346: 1038.